Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Kalorama Information
Kalorama Information
Activities:
Media
Finance
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Media
Fifty per cent of drug discovery work to be outsourced over next 4–5 years, report says
The market is expected to be worth US$21bn in 2016, forecasts Kalorama Information
Media
Vaccine market to reach US$45bn by 2022
Kalorama releases Vaccines 2016: World Market Analysis report
Media
Transdermal patch market grows to US$7bn
New applications continue to emerge for transdermal drug delivery, including migraine, HIV, osteoporosis, stroke and restless leg syndrome treatments
Media
Biopharmaceutical demand drives cell culture supply market up
Research firm Kalorama says growth in development and production of biopharmaceuticals is most significant driver of cell culture market
Media
Proteomics research market reaches US$1.6bn
Instruments such as mass spectrometry, electrophoresis and liquid chromatography that can assist in the identification of drug targets and biomarker validation are in demand, reports Kalorama
Media
Drug patches grow beyond smoking cessation products
Further growth in transdermal drug delivery likely to be driven by the continued expansion of biotechnology drugs
Media
Drug discovery is increasingly outsourced, finds report
Firms in Eastern Europe and Asia chosen for providing cost savings and their expertise
Subscribe now